Skip to content
Search

Latest Stories

Community pharmacists can play key role in integrated NHS: Bharat Shah

The co-founder of Sigma Pharmaceuticals said stronger collaboration among primary healthcare providers can provide patients with the best possible care

Community pharmacists can play key role in integrated NHS: Bharat Shah

COMMUNITY pharmacists can play a key role in an integrated NHS and help improve patient care, an influential business leader in the sector has said.

Bharat Shah, who co-founded Sigma Pharmaceuticals, said stronger collaboration among primary healthcare providers can provide patients with the best possible care by fostering a unified and coordinated approach.


His comments came at the annual Sigma conference, which, this year, was held in Johannesburg, from February 26-29.

More than 220 participants – including influential healthcare leaders and key representatives from the pharma industry – gathered to explore the theme of ‘Community pharmacy in an integrated NHS’.

Sigma CEO Hatul Shah said the conference aimed to “bring influential and innovative people in the sector together to facilitate sharing information and enable patients to get the best possible outcomes.”

He added, “To do this, we need a sustainable sector in community pharmacy. By collaborating and assimilating what our speakers convey, I’m certain we can lead a new generation of healthcare in the UK.”

He praised Pharmacy First as a “crucial first step” in recognising and funding community pharmacies, which patients view as their first point of contact for advice.

Pharmacy First is a new initiative launched across England that enables patients to receive treatments for seven common conditions directly from a pharmacist without a GP’s appointment or prescription. These include sinusitis, sore throat, earache, infected insect bite, impetigo, shingles and uncomplicated urinary tract infections in women.

LEAD Sigma INSET Conference And the Sigmaconference in progress


This year’s event brought together the chief pharmaceutical officers of the four UK nations – David Webb (England), professor Alison Strath (Scotland), Andrew Evans (Wales) and professor Cathy Harrison (Northern Ireland) on one platform.

Webb said the four chief pharmaceutical officers were taking steps to deliver on the recommendations of the independent UK Commission report so that pharmacy leaders and specialist professional groups could “work collaboratively”.

He added that the UK pharmacy professional leadership advisory board, launched in October 2023, will lead the delivery of the vision set out by the commission.

Sir Hugh Taylor has been appointed as its independent chair of the advisory board, which involves the eight pharmacy bodies and the Academy of Medical Royal Colleges. Webb said they are currently recruiting independent expert members of the board, with a first meeting later this month.

The UK Commission on Pharmacy Professional Leadership focuses on five themes – leadership, policy and professionalism; regulatory support; regional, country and international relations and engagement; the scope of practice for future pharmacy professionals; and professional education and training.

Strath also emphasised the importance of collaboration and using skills, capabilities and capacity across all organisations to have a “common focus and a shared vision.”

Evans said they were transforming community pharmacy in Wales to meet the needs of the NHS and the citizens of the country, building on the strengths of the sector.

Among other key points of transformation, Evans spoke about integrating community pharmacy within the wider health and care system as well as ensuring adequate funding by making the sector “an investable proposition” in the eyes of the commissioners and the government.

Sharing the community pharmacy strategic vision 2023, professor Harrison said the skills of community pharmacists will be fully utilised to “increase capacity within health and social care, to manage demand and support people to maintain their wellbeing and lead healthy, active lives.”

Community pharmacy consultant Hemant Patel was also among the distinguised speakers. He called for collaboration in the industry and moving away from “isolated operations” and competing for “funding and personnel.”

Patel also stressed the importance of developing a “shared vision” at the local level.

Sigma is one of the largest independent short-line pharmacy wholesalers in the UK, serving independent pharmacies, dispensing doctors and hospitals for over 40 years.

It provides an industry-leading range that includes generics, branded medicines, OTC medicines, parallel imports and unlicensed medicines.

More For You

The Sattva Collective launches to support South Asian women

The initiative will empower more women to speak openly about their health

iStock

The Sattva Collective launches to support South Asian women through midlife and menopause

A new community-led initiative has been launched in the UK to provide culturally sensitive support for South Asian women navigating midlife and menopause.

The Sattva Collective, founded by certified Midlife and Menopause Coach Kiran Singh, officially launched on 14 May 2025 as a registered Community Interest Company (CIC). It is the first initiative in the UK focused specifically on the experiences of South Asian women during what Singh describes as a “deeply personal and often stigmatised” phase of life.

Keep ReadingShow less
Bella Hadid

Bella Hadid stuns at the Cannes Film Festival 2025 in a daring Saint Laurent black gown

Instagram/ Vogue France

Bella Hadid pushes Cannes 2025 dress code to the edge in a daring Saint Laurent black gown

Bella Hadid’s return to the Cannes Film Festival was anything but quiet. This year, the model showed up ready to challenge the red carpet rules without actually breaking them.

With new restrictions in place like no sheer fabrics, no visible nudity, no dramatic trains or bulky silhouettes, fashion-watchers wondered if Bella, known for her daring Cannes looks in the past, would tone it down. Instead, she found a clever way around the rules.

Keep ReadingShow less
Gen Z

These terms provide insight into how Gen Z views the world around them

iStock

11 Gen Z slang terms that have already peaked in 2025

Language is constantly evolving, and nowhere is this more apparent than in the lexicon of Gen Z. As the first generation to grow up fully immersed in social media, their language is influenced by memes, viral videos, and digital culture. With 2025 underway, several Gen Z slang terms have already become ubiquitous, appearing in everyday conversations, on social media platforms, and even in mainstream media. Here are 11 slang terms that have already peaked this year.

1. Delulu

"Delulu," short for "delusional," is one of the most prominent slang terms of 2025. It’s used to describe someone who holds unrealistic beliefs or makes outlandish claims. The term was catapulted into the spotlight after Australian Prime Minister Anthony Albanese used it in Parliament to describe his political opponents, referring to them as being "delulu with no solulu," which translates to "delusional with no solution." The term has since been widely adopted by young people, particularly in online communities. It’s now frequently used to poke fun at someone’s exaggerated or disconnected views on social media.

Keep ReadingShow less
FDA Urges Immediate Stop to Use of Recalled Eye Care Products

The FDA has categorised the recall as a Class II

iStock

Eye care products recalled across US over sterility concerns, FDA warns users to stop immediately

A nationwide recall of five eye care products has been issued in the United States after concerns were raised about their sterility and manufacturing standards. BRS Analytical Services, LLC, the manufacturer of the affected products, has urged consumers to stop using them immediately due to potential safety risks.

The recall, shared in a press release by healthcare distributor AvKARE, affects more than 1.8 million cartons of eye drops. The US Food and Drug Administration (FDA) identified multiple violations during a recent audit, including failures to meet Current Good Manufacturing Practice (CGMP) standards.

Keep ReadingShow less
Zepbound Surpasses Wegovy in Groundbreaking Weight Loss Study

This may influence future decisions on treatment options for obesity patients

iStock

Eli Lilly's Zepbound outshines Wegovy in weight loss trial results

Eli Lilly announced on Sunday that its weight-loss drug, Zepbound, outperformed Novo Nordisk's Wegovy in a head-to-head trial, showing superior results across five weight-loss targets, including waist circumference reduction.

This trial, the first of its kind comparing the two widely used obesity medications, offers Eli Lilly a competitive advantage as it aims to secure broader insurance coverage in the rapidly growing obesity drug market, which is projected to exceed $150 billion annually by the next decade.

Keep ReadingShow less